Toxoplasma gondii: Determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts

Experimental Parasitology

Volumn 130, Issue 1, 2012, Pages 22-25

  Chew, Wai Kit ^a   Wah, Mak Joon ^a   Ambu, Stephen ^a   Segarra, Ignacio ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Brain chronic toxoplasmosis onset; In vitro reactivation; Toxoplasma gondii

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRAIN CYST; CONTROLLED STUDY; CYST (RESTING STAGE); DISEASE COURSE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERO CELL;

ANIMALS; BRAIN; CERCOPITHECUS AETHIOPS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; IMMUNOCOMPROMISED HOST; MALE; MICE; MICE, INBRED BALB C; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; VERO CELLS;

MUS; TOXOPLASMA GONDII;

EID: 84855965820     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.10.004     Document Type: Article

References (29)

1. Alvarado-Esquivel C., Alanis-Quiñones O.P., Arreola-Valenzuela M.A., Rodríguez-Briones A., Piedra-Nevarez L.J., Duran-Morales E., Estrada-Martínez S., Martínez-García S.A., Liesenfeld O. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infectious Diseases 2006, 19(6):178.
2. Brenier-Pinchart M.P., Blanc-Gonnet E., Marche P.N., Berger F., Durand F., Ambroise-Thomas P., Pelloux H. Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro. Acta Neuropathologica 2004, 107:245-249.
3. Carruthers V.B., Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophrenia Bulletin 2007, 33:745-751.
4. Cook A.J., Gilbert R.E., Buffolano W., Zufferey J., Petersen E., Dunn D.T. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European research network on congenital toxoplasmosis. British Medical Journal 2000, 321:142-147.
5. Daryani A., Sharif M., Hosseini S.H., Karimi S.A., Gholami S. Serological survey of Toxoplasma gondii in schizophrenia patients referred to psychiatric hospital, Sari city, Iran. Tropical Biomedicine 2010, 27:476-486.
6. Djurković-Djaković O., Nikolić T., Robert-Gangneux F., Bobić B., Nikolić A. Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis. Antimicrobial Agents and Chemotherapy 1999, 43:2240-2244.
7. Dunay I.R., Heimesaat M.M., Bushrab F.N., Muller R.H., Stocker H., Arasteh K., Kurowski M., Fitzner R., Borner K., Liesenfeld O. Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated Toxoplasmosis. Antimicrobial Agents and Chemotherapy 2004, 48:4848-4854.
8. Fekadu A., Shibre T., Cleare A.J. Toxoplasmosis as a cause for behaviour disorders-overview of evidence and mechanisms. Folia Parasitologica 2010, 57:105-113.
9. Ferreira da Silva M.F., Barbosa H.S., Gross U., Lüder C.G. Stress-related and spontaneous stage differentiation of Toxoplasma gondii. Molecular BioSystems 2008, 4:824-834.
10. Freyre A., Falcón J., Méndez J., Gastell T., Venzal J.M. Toxoplasma gondii: cross-immunity against the enteric cycle. Experimental Parasitology 2007, 115:48-52.
11. Grujic J., Djurkovic-Djakovic O., Nikolic A., Klun I., Bobic B. Effectiveness of Spiramycin in murine models of acute and chronic toxoplasmosis. Journal of Antimicrobial Agents 2005, 25:226-230.
12. Hassan M., Hegab M., Abaza B.E., Nasr M.E., Mowafy N.M. Specific anti-Toxoplasma antibodies in relation to infection and reinfection using different infective stages. Journal of the Egyptian Society of Parasitology 1999, 29:119-129.
13. Israelski D.M., Remington J.S. Toxoplasmosis in the non-AIDS immunocompromised host. Current Clinical Topics in Infectious Diseases 1993, 13:322-356.
14. Jean M.W., Chatterton R., Evans D., Ashburn A.W., Joss L., Ho Yen D.o. Toxoplasma gondii in vitro culture for experimentation. Journal of Microbiological Methods 2002, 51:331-335.
15. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 1992, 15:211-222.
16. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
17. Ortiz-Alegría L.B., Caballero-Ortega H., Cañedo-Solares I., Rico-Torres C.P., Sahagún-Ruiz A., Medina-Escutia M.E., Correa D. Congenital toxoplasmosis: candidate host immune genes relevant for vertical transmission and pathogenesis. Genes and Immunity 2010, 11:363-373.
18. Parker G.A., Langloss J.M., Dubey J.P., Hoover E.A. Pathogenesis of acute toxoplasmosis in specific-pathogen-free cats. Veterinary Pathology 1981, 18:786-803.
19. Porter S.B., Sande M. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. New England Journal of Medicine 1992, 327:1643-1648.
20. Prandota J. Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis. International Journal of Neuroscience 2009, 119:1655-1692.
21. Rajapakse R., Uring-Lambert B., Andarawewa K.L., Rajapakse R.P., Abou-Bacar A., Marcellin L., Candolfi E. 1, 25(OH) 2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii. Journal of Steroid Biochemistry and Molecular Biology 2007, 103:811-814.
22. Schoondermark-Van de Ven E., Melchers W., Camps W., Eskes T., Meuwissen J., Galama J. Effectiveness of spiramycin for treatment of congenital toxoplasma gondii infection in rhesus monkeys. Antimicrobial Agents and Chemotherapy 1994, 38:1930-1936.
23. Shen J.L., Hsu P.K. Activation of the latent Toxoplasma infection and cyst formation in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1991, 102:105.
24. Silva R.C., Silva A.V., Langoni H. Recrudescence of Toxoplasma gondii infection in chronically infected rats (Rattus norvegicus). Experimental Parasitology 2010, 125:409-412.
25. Skariah S., McIntyre M.K., Mordue D.G. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitology Research 2010, 107:253-260.
26. Takashima Y., Suzuki K., Xuan X., Nishikawa Y., Unno A., Kitoh K. Detection of initial site of Toxoplasma gondii reactivation in brain tissue. International Journal of Parasitology 2007, 10:1-9.
27. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. International Journal Parasitology 2000, 30:17-58.
28. Troyo A., Chinchilla M. In vitro multiplication of Toxoplasma gondii and Trypanosoma cruzi in mouse, rat and hamster astrocytes. Revista de Biologia Tropical 2003, 51:639-646.
29. Webster J.P., Lamberton P.H.L., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood- stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings of The Royal Society B 2006, 273:1023-1030.